These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7697692)

  • 21. Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months.
    Birkeland KI; Furuseth K; Melander A; Mowinckel P; Vaaler S
    Diabetes Care; 1994 Jan; 17(1):45-9. PubMed ID: 8112188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective studies of muscle capillary basement membrane width in prediabetics.
    Feingold KR; Browner WS; Siperstein MD
    J Clin Endocrinol Metab; 1989 Oct; 69(4):784-9. PubMed ID: 2778035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM.
    Feinglos M; Dailey G; Cefalu W; Osei K; Tayek J; Canovatchel W; Chaiken R; Kourides I
    Diabetes Res Clin Pract; 2005 May; 68(2):167-75. PubMed ID: 15860246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thickening of the capillary basement membrane of the quadriceps muscle in Vacor-induced diabetic patients.
    Lee TH; Choi KC; Park YK; Choi JK
    Diabetes Res Clin Pract; 1985 Oct; 1(3):155-9. PubMed ID: 3836103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.
    Cefalu WT; Schneider DJ; Carlson HE; Migdal P; Gan Lim L; Izon MP; Kapoor A; Bell-Farrow A; Terry JG; Sobel BE
    Diabetes Care; 2002 Dec; 25(12):2123-8. PubMed ID: 12453948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
    Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
    Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
    Madsbad S; Kilhovd B; Lager I; Mustajoki P; Dejgaard A;
    Diabet Med; 2001 May; 18(5):395-401. PubMed ID: 11472451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus.
    Kitabchi AE; Kaminska E; Fisher JN; Sherman A; Pitts K; Bush A; Bryer-Ash M
    Am J Med Sci; 2000 Mar; 319(3):143-8. PubMed ID: 10746824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Mar; 210(6):772-7. PubMed ID: 9074678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle capillary basement-membrane thickness and long-term glycemia in type I diabetes mellitus.
    Sosenko JM; Miettinen OS; Williamson JR; Gabbay KH
    N Engl J Med; 1984 Sep; 311(11):694-8. PubMed ID: 6472356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
    Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combined use of insulin and sulfonylurea therapy in patients with non-insulin dependent diabetes mellitus.
    Reaven GM; Fraze E; Chen NY; Hollenbeck C; Chen YD
    Horm Metab Res; 1989 Mar; 21(3):132-6. PubMed ID: 2663691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Durability of the efficacy and safety of alogliptin compared with glipizide in type 2 diabetes mellitus: a 2-year study.
    Del Prato S; Camisasca R; Wilson C; Fleck P
    Diabetes Obes Metab; 2014 Dec; 16(12):1239-46. PubMed ID: 25132212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of muscle capillary basement membrane thickness and diabetic retinopathy.
    Klein RF; Feingold KR; Morgan C; Stern WH; Siperstein MD
    Diabetes Care; 1987; 10(2):195-9. PubMed ID: 3582080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylated hemoglobin concentration for assessment of glycemic control in diabetic cats.
    Elliott DA; Nelson RW; Feldman EC; Neal LA
    J Vet Intern Med; 1997; 11(3):161-5. PubMed ID: 9183767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].
    Nauck M; del Prato S; Meier JJ; Durán-García S; Rohwedder K; Elze M; Parikh SJ
    Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S6-15. PubMed ID: 23529570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
    Bao YQ; Zhou J; Zhou M; Cheng YJ; Lu W; Pan XP; Tang JL; Lu HJ; Jia WP
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.